To further demonstrate the potential prognostic value of RNase1 in patients with HCC who receive immunotherapy, we examined the expression of RNase1 and the infiltration of CD8+ T cells in another independent HCC cohort (Supplementary Table 5). The gene discussed is RNASE1; the disease is hepatocellular carcinoma.